Author Archives: Brad Oliver

January 26, 2022
FeaturedIn The News
Read Article
January 25, 2022
FeaturedPress Release

CSO, CFO, and GC added as technology-enabled pharma company bolsters growing management team and SAB SAN FRANCISCO, Calif. — January 25, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today the appointment of David Thomson, Ph.D. as Chief Scientific Officer. Additional management team appointments include Jonathan Barr […]

Read Article
January 5, 2022
Press Release

Leading AI-pharma company among select few private companies to participate San Francisco, CA – January 5, 2022 – Atomwise, a technology-enabled pharmaceutical company leveraging the power of artificial intelligence (AI) to revolutionize small molecule drug discovery, today announced that it has been invited to present next week at the 40th Annual J.P. Morgan Healthcare Conference. […]

Read Article
September 13, 2021
In The News
Read Article
August 17, 2021
In The News
Read Article
June 24, 2021
In The News
Read Article